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Abstract
Background: Ethanol extract of propolis (EEP), rich in flavones, has been known for various biological activities including
antioxidant, antiinflammatory and antibiotic activities. Our previous studies have shown that EEP protects endothelial
cells from oxidized low-density lipoprotein (ox-LDL)-induced apoptosis and inhibits atherosclerotic lesion development.
In this present study, we explored the protective effect of EEP on ox-LDL-induced cytotoxicity in macrophages and
specifically the endoplasmic reticulum (ER) stress-C/EBP homologous protein (CHOP) pathway-mediated apoptosis.
Methods: EEP was prepared and the total flavonoids content of EEP was determined by the colorimetric method of
Chinese Standard (GB/T 20574-2006). The effects of EEP on lipid accumulation, cytotoxicity and apoptosis in RAW264.7
cells induced by ox-LDL or tunicamycin (TM, an ER stress inducer) were assayed using oil red O staining, MTT assay, flow
cytometric analysis and so on. Immunofluorescence, Western blot and real time-PCR analysis were then used to further
investigate the molecular mechanisms by which EEP protects macrophages from ox-LDL-induced apoptosis.
4-phenylbutyric acid (PBA), an ER stress inhibitor, was used as a positive control.
Results: EEP (7.5, 15 and 30 mg/L) not only attenuated ox-LDL-induced lipid accumulation in RAW264.7 macrophages
in a dose-dependent manner but also inhibited the decreased cell viability and the increased lactate dehydrogenase
(LDH) leakage, caspase-3 activation and apoptosis induced by ox-LDL or tunicamycin (TM, a classical ER stress inducer),
which were similar to 4-phenylbutyric acid (PBA, an inhibitor of ER stress) treatment. In addition, like PBA, EEP
significantly suppressed the ox-LDL- or TM-induced activation of ER stress signaling pathway including the
phosphorylation of double-stranded RNA-activated protein kinase-like ER kinase (PERK) and eukaryotic translation
initiation factor 2α (eIF2α) as well as upregulation of glucose regulated protein 78 (GRP78) and the pro-apoptotic
protein CHOP. Furthermore, EEP significantly suppressed ox-LDL intake by macrophages and the upregulation of CD36
induced by ox-LDL.
Conclusion: These data indicate that EEP may protect macrophages from ox-LDL-induced apoptosis and the
mechanism at least partially involves its ability to suppress the CD36-mediated ox-LDL intake and subsequent activation
of ER stress-CHOP signalling pathway.
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Background
Apoptosis, especially in macrophages-dense atheroscler-
otic lesions, is unanimously considered as a prominent
feature of advanced atherosclerotic plaques, suggesting
that macrophage apoptosis is closely related to the
atherosclerotic development and subsequent plaque
rupture, which is the prominent event that results in the
majority of clinical manifestations of acute coronary
syndrome such as acute myocardial infarction and sudden
coronary death [1]. Macrophage apoptosis at early stages,
combined with efficient clearance of apoptotic cells
(efferocytosis), helps in maintaining reduced cellularity
and slows lesion progression. However in advanced
atherosclerotic lesions where efferocytosis is defective,
apoptosis of macrophage- derived foam cells contributes
to the formation and expansion of lipid core, and gives rise
to inflammation and necrosis, which lead to plaque in-
stability [2]. Thus, protecting macrophages from apoptosis
is believed as an effective approach to attenuate plaque in-
stability and combat acute vascular events [3].
Propolis, a resinous hive product collected by honey-
bees from many plant sources, contains predominantly
phenolic compounds including flavonoids, phenolic
acids and their esters [4–6]. Propolis has a long history
of being used in traditional medicine because of its
broad spectrum of biological activities incoluding
anticancer, antioxidant, antiinflammatory, antibiotic and
antifungal properties [7]. Recent studies have shown that
ethanol extract of propolis (EEP), rich in flavones, has
inhibitory effects on inflammatory responses and
inflammation-related transcription factors in macro-
phages [8, 9]. In our previous studies, we have found
that EEP promotes reverse cholesterol transport and
restrians atherosclerotic lesion development [10, 11].
More interestingly, our previous studies have shown that
EEP protects endothelial cells from oxidized low density
lipoprotein (ox-LDL)-induced injury by inhibiting lectin-
like oxidized low density lipoprotein receptor-1 (LOX-1)-
mediated oxidative stress [12]. However, whether EEP
protects macrophages from ox-LDL-induced apoptosis by
inhibiting endoplasmic reticulum (ER) stress-C/EBP
homologous protein (CHOP) pathway has not yet been
determined.
CHOP, belonging to C/EBP transcription factor family,
is a specific transcription factor in ER stress [13]. ER
stress-CHOP pathway-mediated apoptosis in macro-
phages has been confirmed to promote the instability of
atherosclerotic plaques, and the deficiency of CHOP has
been discovered to prevent macrophages from ER stress-
induced apoptosis in vitro and in advanced atherosclerotic
lesions of mice [14, 15]. Therefore, a positive correlation
among CHOP expression, apoptosis of macrophages and
progression of atherosclerotic plaques to the vulnerable
stage is undoubted [2, 15, 16]. We have previously
reported that both minimally modified LDL (mm-LDL)
and ox-LDL can induce ER stress during the formation of
macrophage-derived foam cells, and double-stranded
RNA-activated protein kinase-like ER kinase (PERK)
mediates ox-LDL-induced macrophage apoptosis by up-
regulating CHOP expression [17, 18]. In addition, our
earlier study has provided preliminary evidence that quer-
cetin, one of the flavonoids that are ubiquitous in plants
and propolis, protects macrophages from ox-LDL-induced
apoptosis by inhibiting CHOP expression [19]. Therefore,
we hypothesize that EEP may protect macrophages from
ox-LDL-induced apoptosis through suppressing ER stress-
CHOP signalling pathway. In this present study, we ex-
plored the protective effect of EEP on ox-LDL-induced
cytotoxicity in RAW264.7 macrophages and specifically
the ER stress-CHOP pathway-mediated apoptosis.
Methods
Reagents
Tunicamycin (TM), oil red O, 4-phenylbutyric acid (PBA)
and rabbit antibody against β-actin were purchased from
Sigma-Aldrich (St Louis, MO, USA). Dulbecco’s modified
Eagle medium (DMEM) and fetal bovine serum (FBS) were
obtained from Gibco (Rockville, MD, USA). RIPA lysis
buffer and DiI-ox-LDL were from Solarbio (Beijing, China)
and Xiesheng Biotech (Beijing, China), respectively. Rabbit
polyclonal antibodies against glucose regulated proteins 78
(GRP78), CHOP, double-stranded RNA-activated protein
kinase-like ER kinase (PERK), eukaryotic translation ini-
tiation factor 2α (eIF2α) and phospho-eIF2α (p-eIF2α)
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Rabbit antibodies against phospho-
PERK (p-PERK) and anti-CD36 monoclonal antibody
(mAb) were purchased from Abcam (Cambridge, MA,
USA). SABC-Cy3 immunohistochemistry kits were ob-
tained from Boshide (Wuhan, China). Annexin V-FITC
apoptosis detection kits, 3-(4,5-dimethylthiazol- 2-y-l)-
2,5-diphenyl-2H-tetrazolium bromide (MTT) and lac-
tate dehydrogenase (LDH) assay kits were obtained
from BD Biosciences (San Jose, CA, USA), Genview
(Houston, TX, USA) and Jiancheng Biotech (Nanjing,-
China), respectively. Enhanced chemiluminescence
(ECL) kits and polyvinylidene fluoride (PVDF) mem-
branes were obtained from Thermo Scientific Pierce
(Rockford, IL, USA) and Millipore (Bedford, MA, USA),
respectively. Caspase-3 activity assay kit and terminal
deoxynucleotidyl transferase-mediated dUTP nick end-
labeling (TUNEL) assay kit were from Calbiochem (San
Diego, CA, USA) and Roche (Mannheim, Germany), re-
spectively. Real-time PCR reagent kits were purchased
from Tiangen Biological Chemistry (Beijing, China).
Tissue/cell total cholesterol (TC) assay kits were ob-
tained from Applygen (Beijing, China).
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Preparation of EEP and total flavonoids measurement
Propolis was harvested from Taishan Mountain in
Shandong province (China) and EEP was prepared as
described in our recent report [12]. Briefly, propolis
powder (100 g) was extracted in 95 % (v/v) ethanol (1 L)
under the condition of sonication at 40 °C for three
times, and then the supernatant were evaporated in a
rotary evaporator under a reduced pressure at 50 °C.
Finally, the EEP was dried in the oven and stored at -20 °C.
The total flavonoids content of EEP was 213.46 ± 2.93 mg
rutin equivalent per gram according to the colorimetric
method of Chinese Standard (GB/T 20574-2006). Immedi-
ately prior to use, EEP sample was dissolved in dimethyl-
sulfoxide (DMSO) and diluted with cell culture medium
into appropriate concentrations.
Isolation and oxidation of LDL
Human LDL was isolated from fresh plasma of healthy
donors using sequential ultracentrifugation, and then
oxidized with 10 μmol/L CuSO4 for 18 h at 37 °C as de-
scribed in our previous study [17]. The use of human
blood and protocol of human LDL isolation were ap-
proved by the Ethics Committee of Taishan Medical
University, and all blood donors provided informed con-
sent for the use of their blood.
Cell culture
RAW264.7 macrophages were purchased from the Type
Culture Collection of the Chinese Academy of Sciences
(Shanghai, China), cultured in DMEM supplemented
with 2 mM glutamine, antibiotics (100 U/ml penicillin
and streptomycin) and 10 % FBS in a 37 °C humidified
incubator containing 5 % CO2 until subconfluent, and
then the medium was replaced with serum-free medium
for 12 h before treatment.
Oil red O staining
The intracellular lipid droplets were stained by oil red O
and the lipid droplet content was expressed as the aver-
age value of the integrated optical density (IOD) as
described previously [17].
Intracellular TC analysis
The intracellular TC concentration was measured using
a tissue/cell TC assay kit according to the manufacturer’s
instructions and normalized to the level of total cellular
protein.
Cell viability and LDH assay
The viability of the treated cells grown in 96-well plates
was evaluated using MTT assay as described previously
[17] and cell viability was expressed as the percentage of
the control group.
The release of the cytosolic LDH into the medium was
used as a generic index of cell injury. After treatment,
the media were collected and assayed for LDH activity
using a LDH activity assay kit according to the manufac-
turer’s instructions.
Flow cytometry analysis of apoptotic cells
The Annexin V-FITC/PI double-staining assay was used
to quantify apoptosis. Cells of each group were collected,
washed with ice-cold PBS twice and centrifuged at 4 °C.
500 μL binding buffer was added to resuspend the cells,
then 5 μL Annexin V-FITC and 5 μL PI were added.
The cells were incubated for 15 min in the dark at room
temperature, and the apoptosis rates were analyzed on a
FACScan flow cytometer using Cell Quest software
(Becton Dickinson, San Jose, CA, USA).
TUNEL staining
DNA strand breaks in the treated macrophages were
detected using the TUNEL staining kit according to the
manufacturer’s instructions. Cells were fixed with 4 %
paraformaldehyde for 30 min at room temperature,
rinsed with PBS, and then incubated in 0.1 % triton
X-100 permeabilisation solution for 2 min on ice. The
TUNEL reaction mixture was added to the cells and in-
cubated for 1 h in a dark humidified chamber at 37 °C.
After incubation, the cells were washed twice for 5 min
in PBS and stained with 4’,6-diamidino-2’-phenylindole
dihydrochloride (DAPI). Cells were detected using a
fluorescence microscope (Olympus, Tokyo, Japan) and
the ratio of TUNEL-positive cells to total cells was
calculated.
Measurement of caspase-3 activity
Caspase-3 activity was identified with an assay kit
according to the manufacturers’ instructions. Briefly,
following treatment, RAW264.7 cells were harvested,
rinsed with PBS and lysed with lysis buffer. The lysate
was centrifuged at 12000 g at 4 °C for 15 min. 20 μl
lysate supernatant was added to 70 μl reaction buffer
and 10 μl caspase-3 substrate, and then the mixture was
incubated in 96-well microtiter plates at 37 °C for 2 h.
Caspase-3 activity was detected by an Infinite F200
microplate reader (Tecan, Switzerland) at 405 nm and
described as a percentage of the control.
Western blot analysis
At the end of treatment, the cells were washed and lysed
in RIPA buffer. Equal amounts of protein were separated
on SDS-PAGE by electrophoresis and then transferred
onto a PVDF membrane. After blocking in 10 % nonfat dry
milk for 2 h at room temperature, the membranes were
probed with primary antibodies overnight at 4 °C and
then incubated with horseradish peroxidase-conjugated
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secondary antibodies for 1 h at room temperature. The
bound immunoproteins were visualized by ECL reac-
tion, and then the intensities were quantified by Image-
Pro Plus software (version 6.0, Media Cybernetics, LP,
USA) and normalized to β-actin levels.
Quantitative real time-PCR analysis
Toal RNA from the treated cells were isolated using
Trizol reagent (Invitrogen), and synthesized to cDNA
using MuLV Reverse Transcriptase. Real-time PCR were
performed on a Rotor-Gene Q real-time PCR cycler
(Qiagen, Shanghai, China) using SYBR-green PCR master
mix kits as described previously [17, 19]. The primers were
synthesized by Sangon Biotech (Shanghai, China) and the
oligonucleotide sequences were as follows: CHOP: 5’-
CCACCACACCTGAAAGCAGAA-3’(forward primer), 5’-
GGTGCCCCCAATTTCATCT-3’(reverse primer); GRP78:
5’-ACATGGACCTG TTCCGCTCTA-3’ (forward primer),
5’-TGGCTCCTTGCCATTGAAGA-3’ (reverse primer);
β-actin: ’-CGGGGACCTGACTGACTACC-3’ (forward
primer), 5’-AGGA AGGCTGGAAGAGTGC-3’ (reverse
primer). The data were analyzed using the Rotor- Gene Q
software (version 1.7, Qiagen), and then relative mRNA
levels were calculated by the 2–△△Ct method.
Uptake of Dil-ox-LDL
Cells were pretreated with EEP (7.5, 15 and 30 mg/L) or
anti-CD36 mAb (2 mg/L) for 1 h and then incubated
with Dil-ox-LDL (50 mg/L) for 6 h. Cells were washed
with PBS and lysed in 200 μL lysis buffer. Using an In-
finite F200 microplate reader (Tecan, Switzerland), the
levels of Dil-ox-LDL in cell lysate were quantitated as re-
ported previously [20], and these data were standardized
to the protein concentration of each sample.
The uptake of Dil-ox-LDL by RAW264.7 cells was
further assayed by fluorescence microscopy. Cells were
washed with PBS, fixed with 4 % paraformaldehyde for
20 min, and the cell nuclei was counterstained with
DAPI for 20 min. After washing for three times, the
cells were observed using a fluorescence microscope
(Olympus, Tokyo, Japan) and the mean fluorescence
intensity per cell was calculated using Image-Pro Plus
software 6.0.
Immunofluorescence assay for CD36 expression
The treated cells were fixed with 4 % (w/v) paraformal-
dehyde, blocked with BSA, and then incubated with
CD36 antibody (1:100) overnight at 4 °C. After incubation
with secondary FITC-conjugated antibody and DAPI, the
cells were washed with PBS, mounted in antifade reagent
and then observed using an Olympus BX51 microscopes
as described previously [20].
Statistical analysis
Results are expressed as the mean ± SEM. Statistical ana-
lysis was performed by one-way analysis of variance with
Student–Newmann–Keuls multiple comparison tests
using the SPSS13.0 software for Windows. P-values less
than 0.05 were considered significant.
Results
EEP suppresses ox-LDL-induced lipid cumulation in
RAW264.7 cells
Lipid droplets stained by oil red O were observed signifi-
cantly in RAW264.7 cells treated with 100 mg/L of ox-
LDL for 24 h. However, the ox-LDL-induced cumulation
of lipid droplets was reduced by EEP in a dose-
dependent manner (Fig. 1a and b). Lipid cumulation was
further certified by intracellular TC quantitative assay.
Compared with the control, intracellular TC content
was remarkably increased (3.9-fold) by ox-LDL treat-
ment. However, the effect of ox-LDL was attenuated by
21.3 %, 28.6 % and 41.3 % upon EEP treatment at 7.5, 15
and 30 mg/L, respectively (Fig. 1c).
EEP attenuates cytotoxicity in RAW264.7 cells induced by
ox-LDL or TM
Cytotoxicity of EEP on RAW264.7 cells was assessed by
MTT assay. Except for the concentration of 60 mg/L,
stimulation with EEP at 7.5 up to 30 mg/L for 24 h had no
remarkable effect on cell viability (Fig. 2a). Next, we deter-
mined the protective effect of EEP on ox-LDL-induced cell
death. The treatment with 100 mg/L ox-LDL for 24 h re-
duced cell viability by approximately 47.7 % as measured
using MTT assay. However, preincubation with different
doses of EEP (7.5, 15 and 30 mg/L) increased the cell
viability in a dose-dependent manner compared with cells
treated with ox-LDL (Fig. 2b).
LDH, which leaks from cells after plasma membrane
injury, was determined to further certify the protective
effect of EEP on RAW264.7 cells. As shown in Fig. 2c,
LDH release increased dramaticly in the media after cells
were incubated with ox-LDL. However, pretreatment
with EEP dramaticly reduced the LDH release in a dose-
dependent manner.
To determine the protective effect of EEP on ER stress-
mediated cell death, PBA, an ER stress inhibitor, was used
as a positive control. As shown in Fig. 2b and c, PBA also
prevented the decreased cell viability and the LDH release
induced by ox-LDL. In addition, TM, an ER stress inducer
by inhibiting protein glycosylation, was also used in the
study to develop ER stress model. When cells were prein-
cubated with EEP (30 mg/L) before TM (5 mg/L) treate-
ment for 12 h, the cell viability raised by 32.5 % compared
with TM exposure alone, which was similar to PBA pre-
treatment (Fig. 2d). These data indicated that EEP was
able to restrain ER stress-induced cell death.
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Fig. 1 EEP reduces ox-LDL-induced intracellular lipid accumulation in RAW264.7 cells. a Cells were treated with ox-LDL (100 mg/L) in the absence
or presence of EEP at different concentrations (7.5, 15 and 30 mg/L) for 24 h, and the intracellular lipid droplets were stained by oil red O. Representative
lipid droplet staining images are shown. Scale bar = 20 μm. b The average integrated optical density (IOD) of lipid droplets stained with oil red O from
differentiated macrophage-derived foam cells was calculated. c Under the same conditions as in (a), the intracellular total cholesterol (TC)
content was measured using a tissue/cell TC assay kit. Data are expressed as the mean ± SEM of at least four independent experiments.
**P < 0.01 versus vehicle-treated control; #P < 0.05, ##P < 0.01 versus ox-LDL treatment
Fig. 2 Effects of EEP on ox-LDL- or TM-induced cytotoxicity in RAW264.7 cells. a Determination of the cytotoxic effects of EEP on RAW264.7 cells.
Cells were incubated with the indicated concentrations of EEP for 24 h and cell viability was measured by the MTT assay and expressed as the
percentage of control. b and c EEP inhibits ox-LDL-induced cell death and LDH leakage. RAW264.7 cells were pretreated with EEP (7.5, 15 and
30 mg/L) or PBA (5 mmol/L) for 1 h, and then exposed to ox-LDL (100 mg/L) for 24 h. d EEP inhibits TM-induced cell death. Cells were pretreated
with EEP (30 mg/L) or PBA (5 mmol/L) for 1 h, and then incubated with TM (5 mg/L) for 12 h. Data are expressed as the mean ± SEM of six
independent experiments. *P < 0.05, **P < 0.01 versus vehicle-treated control; #P < 0.05, ##P < 0.01 versus ox-LDL or TM treatment
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EEP attenuates apoptosis in RAW264.7 cells induced by
ox-LDL or TM
To investigate whether EEP could attenuate ox-LDL-
induced apoptosis, the apoptotic rate of the treated cells
were analyzed by flow cytometry. RAW264.7 cells were
induced apoptosis with ox-LDL (100 mg/L) for 24 h,
whereas EEP pretreatment (7.5, 15 and 30 mg/L) attenu-
ated ox-LDL-induced apoptosis in a dose-dependent
manner. Similarly, the inhibitory effect of PBA on ox-
LDL-induced apoptosis was also observed (Fig. 3a).
TUNEL staining was performed to further confirm the
anti-apoptotic effects of EEP. Similar results were ob-
served using cells pretreated with 30 mg/L EEP or
5 mmol/L PBA compared with ox-LDL treatment alone
(Fig. 3b). Additionally, TUNEL analysis showed that the
increase in apoptotic rate induced by TM was attenuated
by the addition of EEP (Fig. 3c).
The activity of caspase-3, a marker of apoptosis,
was also determined in our study. As illustrated in
Fig. 3d and e, the ox-LDL- or TM-induced increase in
caspase-3 activity was remarkably inhibited by EEP in a
dose-dependent manner. Moreover, the ox-LDL-
induced activation of caspase-3 was also inhibited by
PBA (Fig. 3d).
EEP inhibits ox-LDL-induced ER stress response in
RAW264.7 cells
CHOP is involved in the process of apoptosis associated
with ER stress, while PERK is one of important upstream
molecules that play an important role in the induction
of CHOP. 20 Since we confirmed that like PBA, EEP
could attenuate the ox-LDL- and TM-induced apoptosis
in RAW264.7 cells (Fig. 3), we next examined the effect
of EEP on ER stress-CHOP pathway. As seen in Fig. 4 a,
ox-LDL caused significantly the protein upregulation of
p-PERK, p-eIF2α, GRP78 and CHOP in RAW264.7
cells compared with the control cells, which were re-
markably inhibited by EEP in a dose-dependent man-
ner. Consistent with the Western blot results, ox-LDL-
induced upregulation of CHOP and GRP78 mRNA
were also attenuated by EEP (Fig. 4b). Similar results
were obtained using the cells pretreated with PBA
(Fig. 4a and b).
EEP inhibits TM-induced ER stress response in RAW264.7
cells
To further confirm EEP could reduce the apoptosis of
RAW264.7 cells by inhibiting ER stress-CHOP pathway,
we explored the changes of ER stress markers on TM-
induced ER stress model. Similar to the results above,
pretreatment with EEP could inhibit TM-induced phos-
phorylation of PERK and eIF2α and the upregulation of
GRP 78 and CHOP (Fig. 5a and b).
EEP suppresses ox-LDL uptake and CD36 expression in
RAW264.7 cells
Since about 60 %–70 % of macrophage-derived foam cell
formation is caused by CD36-mediated ox-LDL uptake,
which is an important factor to lead to ER stress [20,
21], and EEP suppressed ox-LDL-induced lipid cumula-
tion in RAW264.7 cells (Fig. 1), we next detected
whether the mechanism underlying the regulatory effect
of EEP on ER stress-CHOP pathway could be through
inhibition of CD36 expression. Our results demostrated
that the uptake of Dil-ox-LDL in RAW264.7 cells was
reduced by EEP in a concentration-dependent manner,
which was similar to anti-CD36 mAb treatment (Fig. 6a
and b). In addition, Western blot and immunofluores-
cence results (Fig. 6c and d) showed that ox-LDL-
induced CD36 upregulation was significantly restrained
by EEP, suggesting that EEP may inhibit the uptake of
ox-LDL via supression of CD36 expression.
Discussion
Apoptosis of lipid-containing macrophages in the ad-
vanced atherosclerotic lesion promotes inflammatory re-
sponse, lesional necrosis and enlargement of the lipid
core, which lead to plaque rupture and acute thrombosis
[1, 2]. Thus, inhibition of macrophage apoptosis may be
effective in blocking acute cardiovascular events. In the
present study, we first demonstrated that EEP not only
inhibited ox-LDL-induced macrophage-derived foam cell
formation, injury and apoptosis but also reduced ER
stress inducer TM-induced macrophage injury and
apoptosis, which were similar to PBA (an ER stress in-
hibitor) pretreatment. Second, like PBA, EEP suppressed
ox-LDL or TM-induced ER stress-CHOP pathway via
inhibiting PERK activation. In addition, EEP mitigated
ox-LDL uptake by macrophages and inhibited CD36 up-
regulation induced by ox-LDL. These data indicate that
EEP inhibits ox-LDL-induced macrophage apoptosis by
suppressing CD36-mediated ox-LDL uptake and subse-
quent activation of ER stress-CHOP pathway.
In recent years, natural medicine especially the plant
flavonoids with cardiovascular protective function gained
much attention and were proven to reduce the risk of
cardiovascular desease in vitro and in vivo based on dif-
ferent animal models [22]. Icariin (a prenylated flavonol
glycoside) attenuates cardiac remodelling through down-
regulating myocardial apoptosis in rats with congestive
heart failure [23]. Wogonin suppresses myocardial apop-
tosis induced by ischemia/reperfusion in rats [24]. Quer-
cetin (a member of the bioflavonoid family) is confirmed
to exhibit antiapoptotic properties in various cell types
[25–27]. Acumulating evidence has demonstrated that
EEP and its flavones exhibit anti-inflammatory effects in
macrophages [8, 9]. In addition, our previous studies
have revealed that EEP promotes reverse cholesterol
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Fig. 3 (See legend on next page.)
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transport, protects endothelial cells from ox-LDL-induced
apoptosis and inhibits atherosclerotic lesion development
[10–12]. However, whether EEP could inhibit ox-LDL-
induced macrophage apoptosis remains unkown. Our
results in the present work showed that EEP remarkably
restrained ox-LDL-induced lipid cumulation and macro-
phage insult as reflected by the increased cell viability and
the decreased LDH leakage, caspase-3 activation and
apoptosis, suggesting that EEP is able to attenuate ox-
LDL-induced macrophage-derived foam cell injury.
ER is a critical cell organelle which takes part in cell
accommodation and death [28]. Accumulating data have
indicated that ER stress-mediated apoptosis is associated
with plaque instability in atherosclerosis and its vascular
complications [16]. ER stress is well known to activate
the unfolded protein response (UPR) as an adaptive re-
sponse to the disequilibrium in ER homeostasis through
transient translational inhibition, upregulation of ER
molecular chaperone and activation of ER-associated
degradation (ERAD). However, when such correction is
not satisfactorily achieved due to severe or prolonged ER
stress, the pro-apoptotic signaling pathway will be elic-
ited. One of the important signaling mediators in the ER
stress-mediated apoptosis pathway is CHOP [15, 29].
Numerous studies have demonstrated that CHOP is
markedly elevated and contributes to macrophage
Fig. 4 EEP inhibits ox-LDL-induced ER stress response in RAW264.7 cells. Cells were pretreated with the indicated concentrations of EEP or PBA
(5 mmol/L) in the presence of ox-LDL (100 mg/L) for 24 h, and then the protein (a) and mRNA (b) levels of ER stress markers were evaluated by
Western blot and quantitative real-time PCR, respectively. Data are expressed as the mean ± SEM of at least three independent experiments. *P <
0.05, **P < 0.01 versus vehicle-treated control; #P < 0.05, ##P < 0.01 versus ox-LDL treatment
(See figure on previous page.)
Fig. 3 Effect of EEP on ox-LDL- or TM-induced apoptosis in RAW264.7 cells. a After RAW264.7 cells were treated with EEP (7.5, 15 and 30 mg/L) or
PBA (5 mmol/L) in the presence of ox-LDL (100 mg/L) treatment for 24 h, cell apoptosis was detected using flow cytometry and the total apoptotic
cells (early and late-stage apoptosis) were represented by the right side of the panel (Annexin V staining alone or together with PI). b and c Cells were
pretreated with EEP (30 mg/L) or PBA (5 mmol/L) for 1 h, followed by exposure to ox-LDL (100 mg/L) for 24 h or TM (5 mg/L) for 12 h, and then cell
apoptosis was detected by TUNEL assay. Scale bar =20 μm. d and e Cells were pretreated with the indicated concentrations of EEP or PBA (5 mmol/L)
in the presence of ox-LDL (100 mg/L) for 24 h or TM (5 mg/L) treatment for 12 h, and then caspase-3 activity was determined by colorimetric assay.
Data are expressed as the mean ± SEM of at least four independent experiments. *P < 0.05, **P < 0.01 versus vehicle-treated control; #P < 0.05, ##P < 0.01
versus ox-LDL or TM treatment
Tian et al. BMC Complementary and Alternative Medicine    Page 8 of 12
apoptosis and the instability of atherosclerotic plaques,
whereas CHOP deficiency attenuates macrophage apo-
ptosis and atherosclerotic plaque necrosis, suggesting
that activation of CHOP is the key signaling step in
macrophage apoptosis and plaque instability [14, 15,
30]. PERK is one of upstream molecules that play a crit-
ical role in the induction of CHOP in ER stress. PERK
is type I ER transmembrane protein possessing serine/
threonine kinase activity. Activated PERK in response
to ER stress induces phosphorylation of eIF2α, thereby
reducing the overall protein translational levels, which
attenuates the unfolded protein load in ER. In addition,
eIF2α phosphorylation also facilitates the expression of
the activating transcription factor 4 (ATF4) that trans-
locates into the nucleus and increases CHOP expres-
sion [16]. Our recent work showed that PERK mediated
ox-LDL-induced apoptosis in macrophages by up-
regulating CHOP expression [17]. In the present study,
we discovered that EEP downregulated CHOP expres-
sion as well as inhibiting the phosphorylation of PERK
and eIF2α induced by ox-LDL in RAW264.7 cells,
which was similar to the ER stress inhibitor PBA. TM
has been known to facilitate apoptosis by activating ER
stress signaling pathways [30]. To further confirm the
regulatory effect of EEP on ER stress-CHOP pathways,
the TM-induced macrophage apoptosis model was used
in the present study. Our data revealed that EEP
reduced the TM-induced cytotoxicity and upregulation
of CHOP. The phosphorylation of PERK and eIF2α in-
duced by TM were also dramatically inhibited by EEP.
These results indicate that the inhibition of ox-LDL-
induced apoptosis by EEP is related to the repression of
ER stress-CHOP pathway.
Several observations including our previous studies
have demonstrated that the cumulation of intracellular
cholesterol is a crucial inducer of ER stress and macro-
phage apotosis in vivo and in vitro [17, 18, 31, 32].
CD36, a class B scavenger receptor that is expressed on
a wide variety of cells especially on monocytes/macro-
phages, has been identified as the major receptor re-
sponsible for ox-LDL uptake into macrophages and
cholesterol accumulation [33, 34]. Loss or inhibition of
CD36 resultes in significant decreased ability of macro-
phages to accumulate ox-LDL and cholesteryl, and
protectes against atherosclerotic lesion development
[35–37]. These data point to a significant role of CD36
in atherosclerosis development and suggest it could be
an important target for therapeutic treatment. More
interestingly, our recent study has provided that CD36
silencing attenuates ox-LDL-induced ATF6 nuclear
translocation and GRP78 upregulation, suggesting that
CD36-mediated ox-LDL uptake in macrophages triggers
ER stress response [20]. Our present work showed that
similar to anti-CD36 antibody, EEP significantly suppressed
Fig. 5 EEP inhibits TM-induced ER stress response in RAW264.7 cells. Cells were pretreated with EEP (30 mg/L) in the presence of TM (5 mg/L)
treatment for 12 h, and then the protein (a) and mRNA (b) levels of ER stress markers were evaluated by Western blot and quantitative real-time
PCR, respectively. Data are expressed as the mean ± SEM of at least three independent experiments. *P < 0.05, **P < 0.01 versus vehicle-treated
control; #P < 0.05, ##P < 0.01 versus TM treatment
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ox-LDL intake as well as the upregulation of CD36
induced by ox-LDL, which may be the mechanism for the
inhibitory effect of EEP on the ER stress-CHOP pathway-
mediated macrophage apoptosis induced by ox-LDL.
Conclusions
The present study showed for the first time that EEP
protected macrophages from ox-LDL-induced apoptosis
through the inhibition of the CD36-mediated ox-LDL
intake and subsequent activation of ER stress-CHOP
signalling pathway in vitro. The results might explain
the diverse physiological activities of EEP and emphasize
the pharmacological application of EEP in atherosclerosis-
related diseases.
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